Oblimersen sodium
奥利默森钠
Report date: 2024/07/05 11:15:10
NME
Base Information
Drug NameOblimersen sodium
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[46]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[14]
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesGenta Incorporated
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUT Health San AntonioGenta IncorporatedGenta Development Ltd +[9]
Active IndicationsN/A
Inactive Indications +[46]